4//SEC Filing
Picozza Enrico 4
Accession 0001209191-20-032901
CIK 0001651944other
Filed
May 28, 8:00 PM ET
Accepted
May 29, 4:13 PM ET
Size
9.6 KB
Accession
0001209191-20-032901
Insider Transaction Report
Form 4
DermTech, Inc.DMTK
Picozza Enrico
Director
Transactions
- Purchase
Common Stock
2020-02-28$10.50/sh+76,228$800,394→ 691,613 total(indirect: By HLM Venture Partners IV, L.P.) - Purchase
Series B-1 Convertible Preferred Stock
2020-02-28$10500.00/sh+114.248$1,199,605→ 114.248 total(indirect: By HLM Venture Partners IV, L.P.)→ Common Stock (114,249 underlying)
Holdings
- 6,000
Common Stock
Footnotes (3)
- [F1]These securities are in the form of restricted stock units issued pursuant to the issuer's Amended and Restated 2010 Stock Plan. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. Subject to the reporting person's continued service, all of the restricted stock units shall vest in a single installment on the date of the 2020 annual meeting of the stockholders of the issuer.
- [F2]On February 28, 2020 the Issuer entered into a definitive securities purchase agreement with certain institutional investors (the "Private Placement"). The Private Placement consisted of 2,467,724 shares of common stock at a price of $10.50 per share and approximately 3,199 and 524 shares of Series B-1 Convertible Preferred Stock and Series B-2 Convertible Preferred Stock, respectively, each at a price of $10,500.00 per share. Each share of Series B-1 Convertible Preferred Stock will automatically convert into 1,000 shares of the Issuer's common stock on the first trading day following the approval of the Private Placement by the stockholders of the Issuer, which the Issuer has agreed to seek at a meeting to be held on or before June 30, 2020. The 76,228 shares of common stock and 114.2481 shares of Series B-1 Convertible Preferred Stock reported herein were acquired pursuant to the Private Placement.
- [F3]The reporting person has a pecuniary interest in HLM Venture Associates IV, LLC ("HLM GP"). HLM GP is the general partner of HLM Venture Partners IV, L.P., which owns the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Documents
Issuer
DermTech, Inc.
CIK 0001651944
Entity typeother
Related Parties
1- filerCIK 0001787129
Filing Metadata
- Form type
- 4
- Filed
- May 28, 8:00 PM ET
- Accepted
- May 29, 4:13 PM ET
- Size
- 9.6 KB